Taipei, Taiwan

Hui-Ju Tseng

This inventor holds 1 USPTO granted patent. Top assignee: Taipei Medical University. Active years: 2020.


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Hui-Ju Tseng: Innovator in Hispidulin Synthesis

Introduction

Hui-Ju Tseng is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of chemistry, particularly in the synthesis of hispidulin and its derivatives. His innovative methods have the potential to enhance the efficiency of chemical processes.

Latest Patents

Hui-Ju Tseng holds a patent for a method for preparing hispidulin and its derivatives. The patent outlines a comprehensive approach that includes selective protection of trihydroxybenzaldehyde, regioselective iodination, selective protection, Stille coupling, Baeyer-Villiger oxidation, and basic hydrolysis to obtain a protected intermediate compound. The process continues with alkylation, Claisen-Schmidt condensation, cyclization, and deprotection of the protected intermediate compound to yield hispidulin or its derivatives. This method is noted for its concise reaction steps and high yield, making it an efficient solution for total synthesis.

Career Highlights

Hui-Ju Tseng is affiliated with Taipei Medical University, where he continues to advance his research and innovation in the field of chemistry. His work has garnered attention for its practical applications and contributions to scientific knowledge.

Collaborations

Hui-Ju Tseng has collaborated with notable colleagues, including Kai-Cheng Hsu and Lih-Chu Chiou. These partnerships have fostered a collaborative environment that enhances research outcomes and innovation.

Conclusion

Hui-Ju Tseng's contributions to the synthesis of hispidulin demonstrate his commitment to advancing chemical research. His innovative methods and collaborations position him as a significant figure in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…